Preparation, Characterization and Antioxidant Evaluation of Poorly Soluble Polyphenol-Loaded Nanoparticles for Cataract Treatment

Cataract, one of the leading causes of blindness worldwide, is a condition in which complete or partial opacity develops in the lens of the eyes, thereby impairing vision. This study aimed to examine the potential therapeutic and protective effects of poorly soluble polyphenols like curcumin, resveratrol, and dibenzoylmethane, known to possess significant antioxidant activity. The polyphenols were loaded into novel lipid-cyclodextrin-based nanoparticles and characterized by particle size, polydispersity index, differential scanning calorimetry, thermogravimetric analysis, X-ray diffraction, scanning electron microscopy (SEM), entrapment efficiency, and release studies. Ferric-reducing ability of plasma and 2,2-diphenyl-1-picrylhydrazyl chemical assays were used to evaluate their antioxidant properties based on their free radical quenching ability. Biochemical in vitro assays were used to examine these polyphenols on hydrogen peroxide-induced formation of cataracts in bovine lenses by estimating total glutathione content and superoxide dismutase activity. Nanoparticles were thermostable and amorphous. Particle size of curcumin, resveratrol, and dibenzoylmethane nanoparticles were 331.0 ± 17.9 nm, 329.9 ± 1.9 nm, and 163.8 ± 3.2 nm, respectively. SEM confirmed porous morphology and XRD confirmed physical stability. Entrapment efficiency for curcumin-, resveratrol-, and dibenzoylmethane-loaded nanoparticles was calculated to be 84.4 ± 2.4%, 72.2 ± 1.5%, and 86.4 ± 0.6%, respectively. In vitro release studies showed an initial burst release followed by a continuous release of polyphenols from nanoparticles. Chemical assays confirmed the polyphenols’ antioxidant activity. Superoxide dismutase and glutathione levels were found to be significantly increased (p < 0.05) after treatment with polyphenol-loaded nanoparticles than pure polyphenols; thus, an improved antioxidant activity translational into potential anticataract activity of the polyphenols when loaded into nanoparticles was observed as compared to pure polyphenols.

[1]  N. Eivazi,et al.  Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. , 2018, Photodiagnosis and photodynamic therapy.

[2]  A. Misra,et al.  Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. , 2018, International journal of pharmaceutics.

[3]  S. Rossi,et al.  Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties. , 2017, Seminars in cancer biology.

[4]  Marwa A. Sallam,et al.  Paliperidone-Loaded Nanolipomer System for Sustained Delivery and Enhanced Intestinal Permeation: Superiority to Polymeric and Solid Lipid Nanoparticles , 2016, AAPS PharmSciTech.

[5]  D. Barrett,et al.  Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice , 2017, Brain : a journal of neurology.

[6]  Nianping Feng,et al.  A Novel Solubility-Enhanced Rubusoside-Based Micelles for Increased Cancer Therapy , 2017, Nanoscale Research Letters.

[7]  M. Forte,et al.  Nano-precipitated curcumin loaded particles: effect of carrier size and drug complexation with (2-hydroxypropyl)-β-cyclodextrin on their biological performances. , 2017, International journal of pharmaceutics.

[8]  S. Barnes,et al.  Small molecules, both dietary and endogenous, influence the onset of lens cataracts. , 2017, Experimental eye research.

[9]  W. Setzer,et al.  A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  N. Udupa,et al.  Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery , 2016, Drug delivery.

[11]  S. Nabavi,et al.  Cytoprotective mechanism of action of curcumin against cataract , 2016, Pharmacological reports : PR.

[12]  A. Abraham,et al.  Lupeol, a pentacyclic triterpenoid isolated from Vernonia cinerea attenuate selenite induced cataract formation in Sprague Dawley rat pups. , 2016, Chemico-biological interactions.

[13]  O. Abdallah,et al.  Gelucire-Based Nanoparticles for Curcumin Targeting to Oral Mucosa: Preparation, Characterization, and Antimicrobial Activity Assessment. , 2015, Journal of pharmaceutical sciences.

[14]  Harsh Chauhan,et al.  Physical-Chemical Characterization and Formulation Considerations for Solid Lipid Nanoparticles , 2015, AAPS PharmSciTech.

[15]  F. Abas,et al.  Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives. , 2015, Bioorganic & medicinal chemistry letters.

[16]  Harsh Chauhan,et al.  Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Harsh Chauhan,et al.  Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques , 2015, Drug development and industrial pharmacy.

[18]  Y. Yu,et al.  Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice , 2015, Human & experimental toxicology.

[19]  Harsh Chauhan,et al.  Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects. , 2014, Journal of pharmaceutical sciences.

[20]  C. Opere,et al.  Lipid peroxidation: pathophysiological and pharmacological implications in the eye , 2013, Front. Physiol..

[21]  S. Kukreja,et al.  The oxidative stress in cataract patients. , 2012, Journal of clinical and diagnostic research : JCDR.

[22]  J. Galano,et al.  Regulation of [3H]D-Aspartate Release by the 5-F2t-Isoprostane and Its 5-Epimer in Isolated Bovine Retina , 2012, Neurochemical Research.

[23]  J. Galano,et al.  Regulation of [3H]D-Aspartate Release by the 5-F2t-Isoprostane and Its 5-Epimer in Isolated Bovine Retina , 2011, Neurochemical Research.

[24]  A. Kong,et al.  Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model. , 2009, Cancer research.

[25]  M. Iinuma,et al.  A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. , 2007, American journal of physiology. Cell physiology.

[26]  A. Kong,et al.  Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. , 2007, Cancer research.

[27]  M. Srinivasan,et al.  The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India , 2006, British Journal of Ophthalmology.

[28]  C. Opere,et al.  Pharmacological consequences of oxidative stress in ocular tissues. , 2005, Mutation research.

[29]  Dejian Huang,et al.  The chemistry behind antioxidant capacity assays. , 2005, Journal of agricultural and food chemistry.

[30]  C. Sánchez-Moreno.  Review: Methods Used to Evaluate the Free Radical Scavenging Activity in Foods and Biological Systems , 2002 .

[31]  Y. P. Lu,et al.  Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. , 1998, Carcinogenesis.

[32]  J J Strain,et al.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.

[33]  A. Spector,et al.  Oxidative stress‐induced cataract: mechanism of action , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  C. Higgins,et al.  Lens opacification by antioestrogens: tamoxifen vs ICI 182, 780 , 1995, British journal of pharmacology.

[35]  T. Shearer,et al.  State of sulfhydryl in selenite cataract. , 1984, Toxicology and applied pharmacology.

[36]  M. S. Blois,et al.  Antioxidant Determinations by the Use of a Stable Free Radical , 1958, Nature.

[37]  P. Siril,et al.  Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs. , 2018, Ultrasonics sonochemistry.

[38]  R. Bodmeier,et al.  Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  C. Opere,et al.  Dual Effect of Isoprostanes on the Release of [3H]D-Aspartate from Isolated Bovine Retinae: Role of Arachidonic Acid Metabolites , 2004, Neurochemical Research.

[40]  B. Özmen,et al.  Superoxide Dismutase and Catalase Activities in Diabetic Cataract , 2002 .